Skip to content

RESPONSE BIOMEDICAL CORP

company.status.inactive

CIK 806888fmd_0EHCNZ2NRJAPDX5BWKF8R6JEZ4Services · Services-Testing LaboratoriesTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2016, 25 periods

Latest annual · FY2015

Millions
Total revenues
15
Gross profit
8
Operating income
0
Net income
(0)
Free cash flow
0

Latest quarter · Q3 FY2016

Millions
Total revenues
2
Gross profit
1
Operating income
(1)
Net income
0
Free cash flow
0
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2012 to FY2015
+9.5%
Revenue, 5 yearsFY2010 to FY2015
n/m
Net income, 5 yearsFY2010 to FY2015
n/m

RESPONSE BIOMEDICAL CORP financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2015FY2014ChangeSource
RevenueCA$15.4 millionCA$11 million+40%10-K 2016-03-24 · proof
Gross profitCA$8.1 millionCA$4.4 million+85%10-K 2016-03-24 · proof
Operating incomeCA$285,000-CA$5 million10-K 2016-03-24 · proof
Net income-CA$150,000-CA$2.1 million10-K 2016-03-24 · proof
Cash from operating activitiesCA$813,000-CA$2.3 million10-K 2016-03-24 · proof
Free cash flowCA$364,000-CA$2.7 million10-K 2016-03-24 · proof
Total assetsCA$11.8 millionCA$13.6 million-13.7%10-Q 2016-05-16 · proof
Total liabilitiesCA$12.5 millionCA$14.5 million-14.1%10-Q 2016-05-16 · proof
Cash and cash equivalentsCA$2.5 millionCA$3.2 million-22%10-K 2016-03-24 · proof
Total debtCA$1.2 millionCA$1.6 million-21%10-Q 2016-05-16 · proof
What was RESPONSE BIOMEDICAL CORP's revenue in fiscal 2015?
RESPONSE BIOMEDICAL CORP reported revenue of CA$15.4 million for fiscal 2015 (the year ended Dec 31, 2015), against CA$11 million the year before (+40%). Source: the 10-K filed with the SEC on Mar 24, 2016. SEC
What was RESPONSE BIOMEDICAL CORP's gross profit in fiscal 2015?
RESPONSE BIOMEDICAL CORP reported gross profit of CA$8.1 million for fiscal 2015 (the year ended Dec 31, 2015), against CA$4.4 million the year before (+85%). Source: the 10-K filed with the SEC on Mar 24, 2016. SEC
What was RESPONSE BIOMEDICAL CORP's operating income in fiscal 2015?
RESPONSE BIOMEDICAL CORP reported operating income of CA$285,000 for fiscal 2015 (the year ended Dec 31, 2015), against -CA$5 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2016. SEC
What was RESPONSE BIOMEDICAL CORP's net income in fiscal 2015?
RESPONSE BIOMEDICAL CORP reported net income of -CA$150,000 for fiscal 2015 (the year ended Dec 31, 2015), against -CA$2.1 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2016. SEC
What was RESPONSE BIOMEDICAL CORP's cash from operating activities in fiscal 2015?
RESPONSE BIOMEDICAL CORP reported cash from operating activities of CA$813,000 for fiscal 2015 (the year ended Dec 31, 2015), against -CA$2.3 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2016. SEC
What was RESPONSE BIOMEDICAL CORP's free cash flow in fiscal 2015?
RESPONSE BIOMEDICAL CORP reported free cash flow of CA$364,000 for fiscal 2015 (the year ended Dec 31, 2015), against -CA$2.7 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2016. SEC
What are RESPONSE BIOMEDICAL CORP's total assets?
As of Dec 31, 2015, RESPONSE BIOMEDICAL CORP reported total assets of CA$11.8 million, against CA$13.6 million a year earlier (-13.7%). Source: the 10-Q filed with the SEC on May 16, 2016 (restated). SEC
What are RESPONSE BIOMEDICAL CORP's total liabilities?
As of Dec 31, 2015, RESPONSE BIOMEDICAL CORP reported total liabilities of CA$12.5 million, against CA$14.5 million a year earlier (-14.1%). Source: the 10-Q filed with the SEC on May 16, 2016 (restated). SEC
What are RESPONSE BIOMEDICAL CORP's cash and cash equivalents?
As of Dec 31, 2015, RESPONSE BIOMEDICAL CORP reported cash and cash equivalents of CA$2.5 million, against CA$3.2 million a year earlier (-22%). Source: the 10-K filed with the SEC on Mar 24, 2016. SEC
What is RESPONSE BIOMEDICAL CORP's total debt?
As of Dec 31, 2015, RESPONSE BIOMEDICAL CORP reported total debt of CA$1.2 million, against CA$1.6 million a year earlier (-21%). Source: the 10-Q filed with the SEC on May 16, 2016 (restated). SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:806888&period_type=annual&limit=5"

Information only, not investment advice.